Graypoint LLC’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$899K Sell
2,217
-488
-18% -$198K 0.05% 231
2025
Q1
$1.35M Buy
2,705
+250
+10% +$124K 0.08% 162
2024
Q4
$1.28M Sell
2,455
-537
-18% -$279K 0.08% 161
2024
Q3
$1.85M Buy
2,992
+41
+1% +$25.4K 0.12% 129
2024
Q2
$1.63M Sell
2,951
-39
-1% -$21.6K 0.11% 133
2024
Q1
$1.74M Buy
2,990
+1,241
+71% +$721K 0.13% 128
2023
Q4
$928K Sell
1,749
-60
-3% -$31.9K 0.07% 175
2023
Q3
$916K Buy
1,809
+230
+15% +$116K 0.09% 159
2023
Q2
$824K Sell
1,579
-495
-24% -$258K 0.08% 151
2023
Q1
$1.2M Buy
2,074
+715
+53% +$412K 0.13% 115
2022
Q4
$748K Buy
1,359
+321
+31% +$177K 0.09% 151
2022
Q3
$527K Buy
1,038
+339
+48% +$172K 0.07% 182
2022
Q2
$380K Buy
699
+194
+38% +$105K 0.05% 214
2022
Q1
$298K Buy
505
+37
+8% +$21.8K 0.03% 266
2021
Q4
$312K Buy
+468
New +$312K 0.03% 247